Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rajyaguru, J. M.
Right arrow Articles by Muszynski, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajyaguru, J. M.
Right arrow Articles by Muszynski, M. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 40, 803-809, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy

ORIGINAL ARTICLES

Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia

JM Rajyaguru and MJ Muszynski
Department of Pediatric Infectious Disease Research, Arnold Palmer Hospital for Children & Women, Orlando, FL 32806, USA. Jayshree@orhs.org

Antibiotic treatment options for Burkholderia cepacia infection are limited because of high intrinsic resistance. The problem is complicated by development of cross-resistance between antibiotics of different classes. We isolated antibiotic-resistant mutants by stepwise exposure to chloramphenicol (Chlor) and to trimethoprim/sulphamethoxazole (T/S) for four B. cepacia strains: ATCC13945, Per (clinical isolate), Cas and D4 (environmental isolates). Chlor(r) mutants did not produce chloramphenicol acetyl-transferase. Cross-resistance, defined as greater than four-fold increase in MIC by microtitre dilution method, was consistently seen in both types of mutants. For chloramphenicol-resistant (Chlor[r]) and trimethoprim/sulphamethoxazole-resistant (Tr/Sr) mutants of B. cepacia ATCC13945 and Cas, no MIC change was seen for piperacillin, ceftazidime, rifampicin, gentamicin, tobramycin, polymyxin B or azithromycin. B. cepacia-Per and -D4 mutants showed cross-resistance to ceftazidime and to piperacillin. Comparison of outer membrane protein (OMP) profiles of B. cepacia and their mutants by SDS-PAGE revealed Tr/Sr) mutants to be deficient in a major OMP (molecular weight 39-47 kDa). Tr/Sr mutants also expressed additional OMPs not found in wild type strains at 75-77 kDa for B. cepacia-ATCC13945 and -Cas, and 20-21 kDa in B. cepacia-D4 and -Per. No OMP changes occurred in Chlor(r) mutants. Lipopolysaccharide (LPS) profiles of each type of mutant showed new high and low molecular weight LPS bands. Cross-resistance seems to be mediated by alterations in porin and LPS for Tr/Sr mutants, but only by LPS in Chlor(r) mutants.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 MicrobiologyHome page
A. Lerner, Y. Okon, and S. Burdman
The wzm gene located on the pRhico plasmid of Azospirillum brasilense Sp7 is involved in lipopolysaccharide synthesis
Microbiology, March 1, 2009; 155(3): 791 - 804.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
C. I. Montero, M. R. Johnson, C.-J. Chou, S. B. Conners, S. G. Geouge, S. Tachdjian, J. D. Nichols, and R. M. Kelly
Responses of Wild-Type and Resistant Strains of the Hyperthermophilic Bacterium Thermotoga maritima to Chloramphenicol Challenge
Appl. Envir. Microbiol., August 1, 2007; 73(15): 5058 - 5065.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. M. Bertot, M. A. Restelli, L. Galanternik, R. C. Aranibar Urey, M. A. Valvano, and S. Grinstein
Nasal Immunization with Burkholderia multivorans Outer Membrane Proteins and the Mucosal Adjuvant Adamantylamide Dipeptide Confers Efficient Protection against Experimental Lung Infections with B. multivorans and B. cenocepacia
Infect. Immun., June 1, 2007; 75(6): 2740 - 2752.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
K. Poole
Efflux-mediated antimicrobial resistance
J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
A. D. Vinion-Dubiel and J. B. Goldberg
Review: Lipopolysaccharide of Burkholderia cepacia complex
Innate Immunity, August 1, 2003; 9(4): 201 - 213.
[Abstract] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. M. Wigfield, G. P. Rigg, M. Kavari, A. K. Webb, R. C. Matthews, and J. P. Burnie
Identification of an immunodominant drug efflux pump in Burkholderia cepacia
J. Antimicrob. Chemother., April 1, 2002; 49(4): 619 - 624.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Giraud, A. Cloeckaert, D. Kerboeuf, and E. Chaslus-Dancla
Evidence for Active Efflux as the Primary Mechanism of Resistance to Ciprofloxacin in Salmonella enterica Serovar Typhimurium
Antimicrob. Agents Chemother., May 1, 2000; 44(5): 1223 - 1228.
[Abstract] [Full Text]

Home page
 J Antimicrob ChemotherHome page
A. S. Ghosh, A. K. Kar, and M. Kundu
Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae
J. Antimicrob. Chemother., February 1, 1999; 43(2): 195 - 201.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.